Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip fracture

BMI Feasible As Pre-Screening Tool for Osteoporosis in Women

Larry Hand  |  

NEW YORK (Reuters Health)—A body mass index (BMI) of less than 28 alone may be a tool to prescreen younger postmenopausal women for osteoporosis, according to a new study. “For young postmenopausal white women aged 50–64, current prescreening modalities identifying candidates for DXA (dual-energy X-ray absorptiometry) scan … are not performing better than BMI alone,”…

Did Reports of Side Effects Contribute to Drop in Bone Drug Use?

Lisa Rapaport  |  

(Reuters Health)—Media reports raising safety concerns about osteoporosis drugs known as bisphosphonates may have contributed to a sharp drop in their use—even though U.S. doctors and drug regulators haven’t recommended against taking them, a study suggests. Fosamax (alendronate sodium) won U.S. marketing approval in 1995. Widespread use of the drug and others like it over…

Rheumatologist Marc C. Hochberg, MD, MPH, Advances Epidemiology Through Collaborative Ties

  |  

Accomplished physician noted for research in gout, osteoarthritis etiology; characterizing therapeutic responsiveness in disease states; inspiring teamwork among rheumatologists

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More

Kathleen Louden  |  

“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.